Table 2.
Confirmed Cases of Age-related Macular Degeneration.
| Endpoint |
Vitamin E (N=19,697) |
Placebo (N=19,724) |
RR* | (95% CI) | P-value |
|---|---|---|---|---|---|
| Visually significant AMD | 117 | 128 | 0.93 | 0.72–1.19 | 0.54 |
| Advanced AMD | 29 | 26 | 1.13 | 0.67–1.92 | 0.65 |
| AMD with or without vision loss | 280 | 313 | 0.90 | 0.77–1.06 | 0.20 |
Abbreviations: AMD, age-related macular degeneration; RR, relative risk; CI, confidence interval
Adjusted for age and aspirin and beta carotene treatment assignment